Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy

Cites (808)

Items 601–800 of 808

1. CTLA-4 Is Expressed by Activated Mouse NK Cells and Inhibits NK Cell IFN-γ Production in Response to Mature Dendritic Cells
   Ana Stojanovic, Nathalie Fiegler, Monika Christine Brunner-Weinzierl, Adelheid Cerwenka · 2014 · The Journal of Immunology
2. Inhibition of Mechanistic Target of Rapamycin Promotes Dendritic Cell Activation and Enhances Therapeutic Autologous Vaccination in Mice
   Eyal Amiel, Bart Everts, Tori C. Freitas, Irah L. King, Jonathan D. Curtis, Erika L. Pearce, Edward J. Pearce · 2012 · The Journal of Immunology
3. Plasmacytoid dendritic cell in immunity and cancer
   Dana K. Mitchell, Sreenivasulu Chintala, Mahua Dey · 2018 · Journal of Neuroimmunology
4. Agonist Antibodies to TNFR Molecules That Costimulate T and NK Cells
   Ignacio Melero, Daniel Hirschhorn-Cymerman, Aizea Morales‐Kastresana, Miguel F. Sanmamed, Jedd D. Wolchok · 2013 · Clinical Cancer Research
5. Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis
   Ewelina Krzywińska, Chahrazade Kantari‐Mimoun, Yann M. Kerdiles, Michal Sobecki, Takayuki Isagawa, Dagmar Gotthardt, Magali Castells, Johannes Haubold, Corinne Millien, Thomas Viel et al. · 2017 · Nature Communications
6. CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest
   Émilie Sick, Albin Jeanne, Christophe Schneider, Stéphane Dedieu, Kenneth Takeda, Laurent Martiny · 2012 · British Journal of Pharmacology
7. Pyruvate Kinase M2 Is Required for the Expression of the Immune Checkpoint PD-L1 in Immune Cells and Tumors
   Eva M. Pålsson‐McDermott, Lydia Dyck, Zbigniew Zasłona, Deepthi Menon, Anne F. McGettrick, Kingston H. G. Mills, Luke A.J. O'Neill · 2017 · Frontiers in Immunology
8. Ultra-High Mass Resolution MALDI Imaging Mass Spectrometry of Proteins and Metabolites in a Mouse Model of Glioblastoma
   Marialaura Dilillo, Rima Ait-Belkacem, Clara Esteve, Davide Pellegrini, Simone Nicolardi, Mario Costa, Eleonora Vannini, Erik L. de Graaf, Matteo Caleo, Liam Andrew McDonnell · 2017 · Scientific Reports
9. Role of T lymphocytes in tumor response to radiotherapy
   Sandra Demaria, Silvia Chiara Formenti · 2012 · Frontiers in Oncology
10. The Role of Interleukin 17 in Tumour Proliferation, Angiogenesis, and Metastasis
    Bob Yang, Heechan Kang, Anthony Fung, Hailin Zhao, Tianlong Wang, Daqing Ma · 2014 · Mediators of Inflammation
11. IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells
    Yumeng Mao, Vincent van Hoef, Xiaonan Zhang, Erik Wennerberg, Julie Lorent, Kristina Witt, Laìa Masvidal, Shuo Liang, Shannon M. Murray, Ola Segnestam Larsson et al. · 2016 · Blood
12. The Kynurenine Pathway is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for Immunotherapy
    Jean‐Pierre Routy, Bertrand Routy, Gina M. Graziani, Vikram Mehraj · 2016 · International Journal of Tryptophan Research
13. Utilizing Chimeric Antigen Receptors to Direct Natural Killer Cell Activity
    David Hermanson, Dan S. Kaufman · 2015 · Frontiers in Immunology
14. Vascular endothelial growth factor restores delayed tumor progression in tumors depleted of macrophages
    Elaine Y. Lin, Jiu-feng Li, Gabriel Bricard, Weigang Wang, Yan Deng, Rani S. Sellers, Steven Anthony Porcelli, Jeffrey W. Pollard · 2007 · Molecular Oncology
15. Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancer
    Shevchenko, Ivan, Karakhanova, Svetlana, Soltek, Sabine, Link, Julia, Bayry, Jagadeesh, Werner, Jens, Umansky, Viktor, Bazhin, Alexandr V. · 2013 · International Journal of Cancer
16. Eosinophilic Granulocytes and Damage-associated Molecular Pattern Molecules (DAMPs)
    Ramin Lotfi, James J. Lee, Michael T. Lotze · 2006 · Journal of Immunotherapy
17. Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cells
    Laurent Boissel, Monica Betancur, Winfried S. Wels, Hande H. Tuncer, Hans Klingemann · 2009 · Leukemia Research
18. Culturing CTLs under Hypoxic Conditions Enhances Their Cytolysis and Improves Their Anti-tumor Function
    Yael Gropper, Tali Feferman, Tali Shalit, Tomer‐Meir Salame, Ziv Porat, Guy Shakhar · 2017 · Cell Reports
19. Ways to Enhance Lymphocyte Trafficking into Tumors and Fitness of Tumor Infiltrating Lymphocytes
    Matteo Bellone, Arianna Calcinotto · 2013 · Frontiers in Oncology
20. Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor‐infiltrating lymphocytes, tumor‐draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer
    Takanori Maruyama, Koji Kono, Yoshiki Mizukami, Yoshihiko Kawaguchi, Kousaku Mimura, Mitsuaki Watanabe, Shinichirou Izawa, Hideki Fujii · 2010 · Cancer Science
21. The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production
    Stefania Laurent, Paola Queirolo, Silvia Boero, Sandra Salvi, Patrizia Piccioli, Simona Boccardo, Simona Minghelli, Anna Morabito, Vincenzo Fontana, Gabriella Pietra et al. · 2013 · Journal of Translational Medicine
22. Cancer immunotherapy: activating innate and adaptive immunity through CD40 agonists
    Gregory Lawrence Beatty, Yan Li, Kristen B. Long · 2016 · Expert Review of Anticancer Therapy
23. Molecular Pathways: Is AMPK a Friend or a Foe in Cancer?
    David Grahame Hardie · 2015 · Clinical Cancer Research
24. Cyclic AMP‐dependent inhibition of human neutrophil oxidative activity by substituted 2‐propynylcyclohexyl adenosine A 2A receptor agonists
    Gail W. Sullivan, Jayson M. Rieger, William Michael Scheld, Timothy L. Macdonald, Joel M Linden · 2001 · British Journal of Pharmacology
25. Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor
    Ida Casella, Tiziana Feccia, Cristiana Chelucci, Paola Samoggia, Germana Castelli, Raffaella Guerriero, Isabella Parolini, Eleonora Petrucci, Elvira Pelosi, Ornella Morsilli et al. · 2003 · Blood
26. Checkpoint inhibitors in breast cancer – Current status
    Anne Dyhl-Polk, Inge Marie Svane, Michael Andersson, Dorte Lisbet Nielsen · 2017 · Cancer Treatment Reviews
27. Interferon γ inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis
    Katharina M Detjen, Katrin Farwig, Martina Welzel, Bertram J. Wiedenmann, Stefan Rosewicz · 2001 · Gut
28. Immune Response Regulation in the Tumor Microenvironment by Hypoxia
    Sara Labiano, Asís Palazón, Ignacio Melero · 2015 · Seminars in Oncology
29. The lack of type I interferon induces neutrophil-mediated pre-metastatic niche formation in the mouse lung
    Ching‐Fang Wu, Lisa Andzinski, Nadine Kasnitz, Andrea Kröger, Frank Klawonn, Stefan Lienenklaus, Siegfried Weiß, Jadwiga Jabłońska · 2015 · International Journal of Cancer
30. Hypoxia-inducible factor 2α regulates key neutrophil functions in humans, mice, and zebrafish
    Alfred A Roger Thompson, Philip M. Elks, Helen M. Marriott, Suttida Eamsamarng, Kathryn R. Higgins, Amy Lewis, Lynne Williams, Selina Parmar, Gary Shaw, Emmet E. McGrath et al. · 2013 · Blood
31. Dendritic cells tolerized with adenosine A2AR agonist attenuate acute kidney injury
    Li L, Liping Huang, Hong Ye, Steven Song, Amandeep Bajwa, Sang Ju Lee, Emily K. Moser, Katarzyna Jaworska, Gilbert R. Kinsey, Yuan Day et al. · 2012 · Journal of Clinical Investigation
32. Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma
    Karim Chamie, Nicholas M. Donin, Pia Klöpfer, Paul Bevan, Barbara Fall, Olaf G. Wilhelm, Stephan Störkel, JONATHAN W. SAID, Michael Gambla, Robert E. Hawkins et al. · 2016 · JAMA Oncology
33. NK Cells in the Tumor Microenvironment
    Stine Kiær Larsen, Yanhua Gao, Per H. Basse · 2014 · Critical Reviews™ in Oncogenesis
34. Immune checkpoint inhibitors in advanced renal cell carcinoma: experience to date and future directions
    Michael B. Atkins, Joseph I. Clark, David I. Quinn · 2017 · Annals of Oncology
35. Induced PD-L1 Expression Mediates Acquired Resistance to Agonistic Anti-CD40 Treatment
    Alfred Zippelius, Jens Schreiner, Petra Herzig, Philipp Müller · 2015 · Cancer Immunology Research
36. Cytokine Stimulation of Epithelial Cancer Cells: The Similar and Divergent Functions of IL-4 and IL-13
    Miranda A. Hallett, Katherine T. Venmar, Barbara Fingleton · 2012 · Cancer Research
37. Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells
    Ivan H. Chan, Renu K. JAIN, Marlowe S. Tessmer, Dan Gorman, Ruban Mangadu, Manjiri Sathe, F Vives, Christina Moon, Ervin Penaflor, Scott P. Turner et al. · 2013 · Mucosal Immunology
38. T cell–derived inducible nitric oxide synthase switches off TH17 cell differentiation
    Jianjun Yang, Ruihua Zhang, Geming Lu, Yu Shen, Liang Peng, Chen Ying Zhu, Miao Cui, Weidong Wang, Paul M. Arnaboldi, Meng Xiong Tang et al. · 2013 · The Journal of Experimental Medicine
39. Distinct arginase isoforms expressed in primary and transformed macrophages: regulation by oxygen tension
    Claudine A. Louis, Jonathan S. Reichner, William L. Henry, Balduino Mastrofrancesco, Tomomi Gotoh, Masataka Mori, Jorge E. Albina · 1998 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
40. Slc3a2 Mediates Branched-Chain Amino-Acid-Dependent Maintenance of Regulatory T Cells
    Kayo Ikeda, Makoto Kinoshita, Hisako Kayama, Shushi Nagamori, Pornparn Kongpracha, Eiji Umemoto, Ryu Okumura, Takashi Kurakawa, Mari Murakami, Norihisa Mikami et al. · 2017 · Cell Reports
41. The A2B Adenosine Receptor Impairs the Maturation and Immunogenicity of Dendritic Cells
    Jeffrey M. Wilson, William G. Ross, Oma N. Agbai, Renea Frazier, Robert A. Figler, Jayson M. Rieger, Joel M Linden, Peter B. Ernst · 2009 · The Journal of Immunology
42. Correlation analysis between frequencies of circulating antigen-specific IgG-bearing memory B cells and serum titers of antigen-specific IgG
    Heike Leyendeckers, Marcus Odendahl, Andrea Löhndorf, Johannes Irsch, Michael Dho Spangfort, Stefan Miltenyi, Nicolas Hunzelmann, Mario Assenmacher, Andreas Radbruch, Jürgen Schmitz · 1999 · European Journal of Immunology
43. Molecular Pathways: Deciphering Mechanisms of Resistance to Macrophage-Targeted Therapies
    Daniela F. Quail, Johanna A. Joyce · 2016 · Clinical Cancer Research
44. Regulatory T cell migration during an immune response
    Yaozhong Ding, Jiangnan Xu, Jonathan S. Bromberg · 2012 · Trends in Immunology
45. CD47 Mediates Killing of Breast Tumor Cells via Gi-Dependent Inhibition of Protein Kinase A
    Partha Pratim Manna, William A. Frazier · 2004 · Cancer Research
46. Molecular mechanisms of TGF‐β antagonism by interferon γ and cyclosporine A in lung fibroblasts
    Oliver Eickelberg, Andreas Pansky, Eleonore S Köhler, Michel Bihl, M. Tamm, Pius Hildebrand, André Paul Perruchoud, Michael J Kashgarian, Michael Roth · 2001 · The FASEB Journal
47. Serine Is an Essential Metabolite for Effector T Cell Expansion
    Eric H. Ma, Glenn R. Bantug, Takla Griss, Stephanie A. Condotta, Radia Marie Johnson, Bożena Samborska, Nello Mainolfi, Vipin Suri, Hannah Guak, Maria Luisa Balmer et al. · 2017 · Cell Metabolism
48. Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib
    Hyun Sik Jun, David A. Weinstein, Young‐Mock Lee, Brian C. Mansfield, JANICE YANG CHOU · 2014 · Blood
49. Crucial Involvement of Tumor-Associated Neutrophils in the Regulation of Chronic Colitis-Associated Carcinogenesis in Mice
    Kun Shang, Yu‐Pan Bai, Chen Wang, Zhen Wang, Hong-Yu Gu, Xiang Du, Xiao-Yan Zhou, Chun-Lei Zheng, Ya-Yun Chi, Naofumi Mukaida et al. · 2012 · PLoS ONE
50. Myeloid-Derived Cells in Tumors: Effects of Radiation
    Ralph E. Vatner, Silvia Chiara Formenti · 2014 · Seminars in Radiation Oncology
51. Hypoxia Modulates HLA-G Gene Expression in Tumor Cells
    Gaël Mouillot, Céline Marcou, Inès Zidi, Christine Guillard, Déborah Sangrouber, Edgardo Delfino Carosella, Philippe Moreau · 2006 · Human Immunology
52. Review of cancer treatment with immune checkpoint inhibitors
    Christiane Thallinger, Thorsten Füreder, Matthias Preusser, Gerwin Heller, Leonhard Müllauer, Christoph Höeller, Helmut Prosch, Natalija Frank, Rafał Świerzewski, Walter Berger et al. · 2017 · Wiener klinische Wochenschrift
53. Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?
    Botticelli, Andrea, Cerbelli, Bruna, Lionetto, Luana, Zizzari, Ilaria, Salati, Massimiliano, Pisano, Annalinda, Federica, Mazzuca, Simmaco, Maurizio, Nuti, Marianna, Marchetti, Paolo · 2018 · Journal of Translational Medicine
54. Role Played by the Programmed Death‐1–Programmed Death Ligand Pathway during Innate Immunity againstMycobacterium tuberculosis
    Ivana B. Alvarez, Virginia Pasquinelli, Javier O. Jurado, Eduardo H Abbate, Rosa María Musella, Silvia de la Barrera, Verónica García · 2010 · The Journal of Infectious Diseases
55. Intra-Tumoral Metabolic Zonation and Resultant Phenotypic Diversification Are Dictated by Blood Vessel Proximity
    Saran Kumar, Husni Sharife, Tirzah Kreisel, Maxim Mogilevsky, Libat Bar-Lev, Myriam Grunewald, Elina Aizenshtein, Rotem Karni, Iddo Paldor, Tomer Shlomi et al. · 2019 · Cell Metabolism
56. A short field guide to fibroblast function in immunity
    Buechler, Matthew B., Turley, Shannon J. · 2018 · Seminars in Immunology
57. ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy
    Messai, Yosra, Noman, Muhammad Zaeem, Hasmim, Meriem, Janji, Bassam, Tittarelli, Andrés, Boutet, Marie, Baud, Véronique, Viry, Elodie, Billot, Katy, Nanbakhsh, Arash et al. · 2014 · Cancer Research
58. The mTOR and PP2A pathways regulate PHD2 phosphorylation to fine-tune HIF1α levels and colorectal cancer cell survival under hypoxia
    Di Conza, Giusy, Trusso Cafarello, Sarah, Loroch, Stefan, Mennerich, Daniela, Deschoemaeker, Sofie, Di Matteo, Mario, Ehling, Manuel, Gevaert, Kris, Prenen, Hans, Zahedi, Rene Peiman et al. · 2017 · Cell Reports
59. Inducible nitric oxide synthase in T cells regulates T cell death and immune memory
    Monika Vig, Smita Srivastava, Usha Kandpal, Hadassah Sade, Virginia Lewis, Apurva Sarin, Anna George, Vineeta Bal, Jeannine Marie Durdik, Satyajit Rath · 2004 · Journal of Clinical Investigation
60. Transcriptional activation of hypoxia-inducible factor-1 (HIF-1) in myeloid cells promotes angiogenesis through VEGF and S100A8
    G‐One Ahn, Jun Seita, Beom-Ju Hong, Young-Eun Kim, Seoyeon Bok, Chan-Ju Lee, Kwang Soon Kim, Jerry C. Lee, Nicholas James Leeper, John P. Cooke et al. · 2014 · Proceedings of the National Academy of Sciences
61. Expression of lactate/H+ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses
    Younghye Kim, Jung-Woo Choi, Jeong Hyeon Lee, Young-Sik Kim · 2014 · Human Pathology
62. Hypoxia-inducible factor 1 in dendritic cells is crucial for the activation of protective regulatory T cells in murine colitis
    Katharina Flück, G. Breves, Joachim Fandrey, Sandra Winning · 2015 · Mucosal Immunology
63. ILC3s integrate glycolysis and mitochondrial production of reactive oxygen species to fulfill activation demands
    Blanda Di Luccia, Susan Gilfillan, Marina Cella, Marco Colonna, Stanley Ching‐Cheng Huang · 2019 · The Journal of Experimental Medicine
64. HDL Induces the Expression of the M2 Macrophage Markers Arginase 1 and Fizz-1 in a STAT6-Dependent Process
    Marie Sanson, Emilie Distel, Edward A A Fisher · 2013 · PLoS ONE
65. PD-1 Expression on Natural Killer Cells and CD8 + T Cells During Chronic HIV-1 Infection
    S. Norris, Adam Coleman, Leticia Kuri-Cervantes, Mark Bower, Mark Richard Nelson, Martin Rhys Goodier · 2012 · Viral Immunology
66. Metabolism and TAM functions—it takes two to tango
    Massimiliano Mazzone, Alessio Menga, Alessandra Castegna · 2017 · FEBS Journal
67. Melanoma cells become resistant to NK ‐cell‐mediated killing when exposed to NK ‐cell numbers compatible with NK ‐cell infiltration in the tumor
    Mirna Balsamo, William Vermi, Monica Parodi, Gabriella Pietra, Claudia Manzini, Paola Queirolo, Silvia Lonardi, Raffaella Augugliaro, Alessandro Moretta, Fabio Facchetti et al. · 2012 · European Journal of Immunology
68. Endothelial Semaphorin 7A promotes neutrophil migration during hypoxia
    Julio C. Morote–Garcia, Daniel Napiwotzky, David Köhler, Peter Rosenberger · 2012 · Proceedings of the National Academy of Sciences
69. Emerging roles of lipid metabolism in cancer progression
    Cyril Corbet, Olivier Féron · 2017 · Current Opinion in Clinical Nutrition & Metabolic Care
70. Checkpoint blockade in Hodgkin and non-Hodgkin lymphoma
    Reid W. Merryman, Philippe A. Armand, Kyle Wright, Scott J. Rodig · 2017 · Blood Advances
71. Influence of hypoxia-inducible factor 1α on dendritic cell differentiation and migration
    Köhler, Theresa, Reizis, Boris, Johnson, Randall S., Weighardt, Heike, Förster, Irmgard · 2012 · European Journal of Immunology
72. Regulation of perforin‐independent NK cell‐mediated cytotoxicity
    Robert P. A. Wallin, Valentina Screpanti, Jakob Michaëlsson, Alf Grandien, Hans‐Gustaf Ljunggren · 2003 · European Journal of Immunology
73. Myeloid-derived suppressor cells contribute to A2B adenosine receptor-induced VEGF production and angiogenesis in a mouse melanoma model
    Claudia Sorrentino, Lucio Miele, Amalia Porta, Aldo Pinto, Silvana Morello · 2015 · Oncotarget
74. Human dendritic cells differentiated in hypoxia down-modulate antigen uptake and change their chemokine expression profile
    Angela Rita Elia, Paola Cappello, Maura Puppo, Tiziana Fraone, Cristina Vanni, Alessandra Eva, Tiziana Musso, Francesco Novelli, Luigi Varesio, Mirella Giovarelli · 2008 · Journal of Leukocyte Biology
75. Cutting Edge: Differentiation of Antitumor CTL In Vivo Requires Host Expression of Stat1
    Francesca Fallarino, Thomas Frank Gajewski · 1999 · The Journal of Immunology
76. CCR2 Influences T Regulatory Cell Migration to Tumors and Serves as a Biomarker of Cyclophosphamide Sensitivity
    Pierre-Louis Loyher, Juliette Rochefort, Camille Baudesson de Chanville, Pauline Hamon, Géraldine Lescaille, Chloé Bertolus, Maude Guillot‐Delost, Matthew F. Krummel, Francois Michel Lemoine, Christophe Combadière et al. · 2016 · Cancer Research
77. E3 Ligase VHL Promotes Group 2 Innate Lymphoid Cell Maturation and Function via Glycolysis Inhibition and Induction of Interleukin-33 Receptor
    Qian Li, Dulei Li, Xian Zhang, Qingqing Wan, Wen Zhang, Mingke Zheng, Le Zou, Chris Elly, Jee H. Lee, Yun‐Cai Liu · 2018 · Immunity
78. The Selective Degradation of Synaptic Connexin 43 Protein by Hypoxia-induced Autophagy Impairs Natural Killer Cell-mediated Tumor Cell Killing
    Tittarelli, Andrés, Janji, Bassam, Van Moer, Kris, Noman, Muhammad Zaeem, Chouaib, Salem · 2015 · Journal of Biological Chemistry
79. RhoA orchestrates glycolysis for TH2 cell differentiation and allergic airway inflammation
    Jun‐Qi Yang, Khalid Wasim Kalim, Yuan Li, Shuangmin Zhang, Ashwini S. Hinge, Marie–Dominique Filippi, Yi Zheng, Fukun Guo · 2015 · Journal of Allergy and Clinical Immunology
80. IL-15 Superagonist–Mediated Immunotoxicity: Role of NK Cells and IFN-γ
    Yin Guo, Liming Luan, Whitney Rabacal, Julia K. Bohannon, Benjamin A. Fensterheim, Antonio Hernandez, Edward R. Sherwood · 2015 · The Journal of Immunology
81. The role of proton dynamics in the development and maintenance of multidrug resistance in cancer
    Chloë Daniel, Charlotte Bell, Christopher Burton, Salvador Harguindey, Stephan J. Reshkin, Cyril Rauch · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
82. Role of Fatty-Acid Synthesis in Dendritic Cell Generation and Function
    Adeel ur Rehman, Keith C. Hemmert, Atsuo Ochi, Mohsin Jamal, Justin R. Henning, Rocky Barilla, Juan P. Quesada, Constantinos Pantelis Zambirinis, Kerry Tang, Melvin Ego-Osuala et al. · 2013 · The Journal of Immunology
83. Genotoxic Stress Induces Senescence-Associated ADAM10-Dependent Release of NKG2D MIC Ligands in Multiple Myeloma Cells
    Alessandra Zingoni, Francesca Cecere, Elisabetta Vulpis, Cinzia Fionda, Rosa Molfetta, Alessandra Soriani, Maria Teresa Petrucci, Maria Rosaria Ricciardi, Daniel Fuerst, Maria Giulia Amendola et al. · 2015 · The Journal of Immunology
84. Chemotherapy-Induced Genotoxic Stress Promotes Sensitivity to Natural Killer Cell Cytotoxicity by Enabling Missing-Self Recognition
    Jason H. Fine, Peter Chen, Aruz Mesci, David Allan, Stephan Gasser, David H. Raulet, James R. Carlyle · 2010 · Cancer Research
85. Transcriptome of Hypoxic Immature Dendritic Cells: Modulation of Chemokine/Receptor Expression
    Annamaria Ricciardi, Angela Rita Elia, Paola Cappello, Maura Puppo, Cristina Vanni, Paolo Fardin, Alessandra Eva, David J. Munroe, Xiaolin Wu, Mirella Giovarelli et al. · 2008 · Molecular Cancer Research
86. VSIG4 expression on macrophages facilitates lung cancer development
    Yunmei Liao, Sheng Jie Guo, Yongwen Chen, Dayan Cao, Huan Xu, Chengying Yang, Lei Fei, Bing Ni, Zhihua Ruan · 2014 · Laboratory Investigation
87. Novel Role for STAT3 in Transcriptional Regulation of NK Immune Cell Targeting Receptor MICA on Cancer Cells
    Romain Bedel, Antoine Thiery-Vuillemin, Camille Grandclément, Jérémy Balland, Jean-Paul Rémy-Martin, Bernadette M. Kantelip, Jean‐René Pallandre, Xavier B. Pivot, Christophe Ferrand, Pierre Tiberghien et al. · 2011 · Cancer Research
88. Anoxia-Induced Up-Regulation of Interleukin-8 in Human Malignant Melanoma
    Manfred Kunz, Anke Hartmann, Egbert Flory, Atiye Toksoy, Dirk Koczan, Hans‐Jürgen Thiesen, Nafoumi Mukaida, Manfred Neumann, Ulf Rüdiger Rapp, Eva‐Bettina Bröcker et al. · 1999 · American Journal Of Pathology
89. Interferon—A Major Regulator of Natural Killer Cell-Mediated Cytotoxicity
    Zvi Reiter · 1993 · Journal of Interferon Research
90. Natural Killer Cells for Cancer Immunotherapy: Pluripotent Stem Cells-Derived NK Cells as an Immunotherapeutic Perspective
    Cristina Eguizábal, Olatz Zenarruzabeitia, Jorge Monge, Silvia D. M. Santos, Miguel Ángel Vesga, Natalia Maruri, Arantza Arrieta, Marta Riñà n, Estíbaliz Tamayo-Orbegozo, Laura Amo et al. · 2014 · Frontiers in Immunology
91. The A2B Adenosine Receptor Promotes Th17 Differentiation via Stimulation of Dendritic Cell IL-6
    Jeffrey M. Wilson, Courtney C. Kurtz, Steven G. Black, William G. Ross, Mohammed S Alam, Joel M Linden, Peter B. Ernst · 2011 · The Journal of Immunology
92. Restricting Glutamine or Glutamine-Dependent Purine and Pyrimidine Syntheses Promotes Human T Cells with High FOXP3 Expression and Regulatory Properties
    Barbara Metzler, Patrick Gfeller, Elisabeth Guinet · 2016 · The Journal of Immunology
93. Aberrant lipid metabolism in cancer cells – the role of oncolipid‐activated signaling
    Upasana Ray, Sib Sankar Roy · 2017 · FEBS Journal
94. Predictive value of HLA-G and HLA-E in the prognosis of colorectal cancer patients
    Zhangyan Guo, Yonggang Lv, Lei Wang, Shengjia Shi, Fan Yang, Guoxu Zheng, Weihong Wen, Angang Yang · 2014 · Cellular Immunology
95. The Intercellular Metabolic Interplay between Tumor and Immune Cells
    Tingting Wang, Guangwei Liu, Ruoning Wang · 2014 · Frontiers in Immunology
96. Macrophage Oxygen Sensing Modulates Antigen Presentation and Phagocytic Functions Involving IFN-γ Production through the HIF-1α Transcription Factor
    Bárbara Acosta‐Iborra, Ainara Elorza, Isabel M. Olazabal, Noa Beatriz Martin-Cofreces, Silvia Martı́n-Puig, Marta Miró, María José Calzada, Julián Aragonés, Francisco Sánchez‐Madrid, Manuel O. Landázuri · 2009 · The Journal of Immunology
97. Opposing roles for HIF-1α and HIF-2α in the regulation of angiogenesis by mononuclear phagocytes
    Timothy D. Eubank, Julie M. Roda, Haowen Liu, Todd O'Neil, Clay B. Marsh · 2010 · Blood
98. Chemokine C ‐ C motif receptor 5 and C ‐ C motif ligand 5 promote cancer cell migration under hypoxia
    Sensen Lin, Shuying Wan, Li Sun, Jialiang Hu, Dongdong Fang, Renping Zhao, Shengtao Yuan, Luyong Zhang · 2012 · Cancer Science
99. Loss of CD73-mediated actin polymerization promotes endometrial tumor progression
    Jessica L. Bowser, Michael R. Blackburn, Gregory L. Shipley, Jose G. Molina, Kenneth Dunner, Russell R. Broaddus · 2015 · Journal of Clinical Investigation
100. Agonistic CD40 mAb-Driven IL12 Reverses Resistance to Anti-PD1 in a T-cell–Rich Tumor
     Shin Foong Ngiow, Arabella Young, Stephen J. Blake, Geoffrey R. Hill, Hideo Yagita∥, Michele W.L. Teng, Alan J. Korman, Mark John Smyth · 2016 · Cancer Research
101. 4-1BB signaling activates glucose and fatty acid metabolism to enhance CD8+ T cell proliferation
     Beom Kyu Choi, Do Y Lee, Don G. Lee, Young H. Kim, Seon-Hee Kim, Ho Sik Oh, Chungyong Han, Byoung Se Kwon · 2016 · Cellular and Molecular Immunology
102. Activation of A2A adenosine receptors inhibits expression of α4/β1 integrin (very late antigen-4) on stimulated human neutrophils
     Gail W. Sullivan, David D. Lee, William G. Ross, Jeffrey A. DiVietro, Courtney M. Lappas, Michael Brandeau Lawrence, Joel M Linden · 2003 · Journal of Leukocyte Biology
103. A Novel NHE1-Centered Signaling Cassette Drives Epidermal Growth Factor Receptor–Dependent Pancreatic Tumor Metastasis and Is a Target for Combination Therapy
     Rosa Angela Cardone, Maria Raffaella Greco, Katrine Zeeberg, Angela Zaccagnino, Mara Saccomano, Antonia Bellizzi, Philipp Bruns, Marta Menga, Christian P. Pilarsky, Albrecht Schwab et al. · 2015 · Neoplasia
104. The Treg/Th17 Paradigm in Lung Cancer
     Minchao Duan, Xiaoning Zhong, Guangnan Liu, Jinru Wei · 2014 · Journal of Immunology Research
105. Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytes
     Chantal Feder‐Mengus, Sourabh Ghosh, William P. Weber, Stephen Frederic Wyler, Paul Zajac, Luigi Terracciano, Daniel Oertli, M. Heberer, Iván Martín, Giulio C. Spagnoli et al. · 2007 · British Journal of Cancer
106. Activation of NK cells and disruption of PD-L1/PD-1 axis: two different ways for lenalidomide to block myeloma progression
     Massimo Giuliani, Bassam Janji, Guy Berchem · 2017 · Oncotarget
107. Tuberous sclerosis 1 (Tsc1)-dependent metabolic checkpoint controls development of dendritic cells
     Yanyan Wang, Gonghua Huang, Hu Zeng, Kai Yang, Richard F. Lamb, Hongbo Chi · 2013 · Proceedings of the National Academy of Sciences
108. Prolyl hydroxylase 2 inactivation enhances glycogen storage and promotes excessive neutrophilic responses
     Pranvera Sadiku, Joseph A. Willson, Rebecca S. Dickinson, Fiona A Murphy, A.J. Harris, Amy Lewis, David Sammut, Ananda S. Mirchandani, Eilíse M. Ryan, Emily Watts et al. · 2017 · Journal of Clinical Investigation
109. Measurements of Oxygen In Vivo : Overview and Perspectives on Methods to Measure Oxygen Within Cells and Tissues
     Roger Springett, Harold M. Swartz · 2007 · Antioxidants and Redox Signaling
110. Th1 and Th2 Cell Clones to a Poorly Immunogenic Tumor Antigen Initiate CD8+ T Cell-Dependent Tumor Eradication In Vivo
     Francesca Fallarino, Ursula Grohmann, Roberta Bianchi, Carmine Vacca, Maria C. Fioretti, Paolo Puccetti · 2000 · The Journal of Immunology
111. Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: An unexpected prognostic significance?
     Leoš Křen, Ondřej Slabý, Katarína Múčková, Eva Lžičařová, Marek Sova, Václav Vybíhal, Tomáš Svoboda, Pavel Fadrus, Radek Lakomý, Petr Vaňhara et al. · 2010 · Neuropathology
112. Endothelins and hypoxia-inducible factor in cancer
     Matthew J. Grimshaw · 2007 · Endocrine Related Cancer
113. IL-22-Mediated Tumor Growth Reduction Correlates with Inhibition of ERK1/2 and AKT Phosphorylation and Induction of Cell Cycle Arrest in the G2-M Phase
     Georg F. Weber, Florian Christoph Gaertner, Wolfgang Erl, Klaus‐Peter Janssen, Birgit Blechert, Bernhard Holzmann, Heike Weighardt, Markus Essler · 2006 · The Journal of Immunology
114. Carbonic Anhydrase IX (CAIX) as a Mediator of Hypoxia-Induced Stress Response in Cancer Cells
     Paul C. McDonald, Shoukat Dedhar · 2013 · Sub-cellular biochemistry/Subcellular biochemistry
115. Preoperative Natural Killer Cell Activity as a Prognostic Factor for Distant Metastasis following Surgery for Colon Cancer
     Eisuke Kondo, Keiji Koda, Nobuhiro Takiguchi, Kenji Oda, Kazuhiro Seike, Mitsuru Ishizuka, Masaru Miyazaki · 2003 · Digestive Surgery
116. The proportion of circulating CD45RO + CD8 + memory T cells is correlated with clinical response in melanoma patients treated with ipilimumab
     Julia K. Tietze, Daniela Angelova, Markus Vincent Heppt, Markus Reinholz, William J. Murphy, Michael Spannagl, Thomas Ruzicka, Carola Berking · 2017 · European Journal of Cancer
117. The Multifaceted Role of Perivascular Macrophages in Tumors
     Claire E. Lewis, Allison S. Harney, Jeffrey W. Pollard · 2016 · Cancer Cell
118. Interferon Regulatory Factor 4 controls TH1 cell effector function and metabolism
     Justus Mahnke, Valéa Schumacher, Stefanie Ahrens, Nadja Käding, Lea Feldhoff, Magdalena Huber, Jan Rupp, Friederike Raczkowski, Hans‐Willi Mittrücker · 2016 · Scientific Reports
119. Hypoxia stimulus: An adaptive immune response during dendritic cell maturation
     Inés Rama, Bernhard Brüne, Joan Torrás, R. Koehl, Josep Maria Cruzado, Oriol Bestard, Marcella Franquesa, Núria Lloberas, Andreas Weigert, I. Herrero et al. · 2008 · Kidney International
120. Neutrophils from patients with heterozygous germline mutations in the von Hippel Lindau protein (pVHL) display delayed apoptosis and enhanced bacterial phagocytosis
     Sarah R. Walmsley, Andrew S. Cowburn, Menna Ruth Clatworthy, Nicholas W. Morrell, E. C. Roper, Vanessa Singleton, Patrick Henry Maxwell, Moira K. B. Whyte, Edwin R. Chilvers · 2006 · Blood
121. Dynamic regulation of Th17 differentiation by oxygen concentrations
     A. Ikejiri, Shigenori Nagai, Nobuhito Goda, Yutaka Kurebayashi, Mayuko Osada‐Oka, Keiyo Takubo, Toshio Suda, Shigeo Koyasu · 2011 · International Immunology
122. Immunologic and Clinical Effects of Targeting PD-1 in Lung Cancer
     Robert Donald Harvey · 2014 · Clinical Pharmacology & Therapeutics
123. Hypoxia optimises tumour growth by controlling nutrient import and acidic metabolite export
     Scott K. Parks, Yann Cormerais, Ibtissam Marchiq, Jacques Pouysségur · 2015 · Molecular Aspects of Medicine
124. Immunosuppressive activity enhances central carbon metabolism and bioenergetics in myeloid-derived suppressor cells in vitro models
     Inès Hammami, Jingkui Chen, Frédéric Murschel, Vincenzo Bronte, Grégory De Crescenzo, Mario Jolicœur · 2012 · BMC Cell Biology
125. Hypoxia-inducible factor-2α regulates GM-CSF–derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis
     Roda, Julie M, Sumner, Laura A, Evans, Randall, Phillips, Gary S, Marsh, Clay B, Eubank, Timothy D · 2011 · The Journal of Immunology
126. New insights into HLA ‐G mediated tolerance
     Giada Amodio, Rafael Sales de Albuquerque, Silvia Gregori · 2014 · Tissue Antigens
127. Cholesterol regulation of receptor‐interacting protein 140 via microRNA‐33 in inflammatory cytokine production
     Ping‐Chih Ho, Kun‐Che Chang, Ya-Shan Chuang, Li‐Na Wei · 2011 · The FASEB Journal
128. Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis
     Emilia K. Andersson, Isabel C. Poschke, Lisa Elena Esther Villabona, Joseph W. Carlson, Andreas Lundqvist, Rolf W. Kiessling, Barbara Seliger, Giuseppe Valentino Masucci · 2015 · OncoImmunology
129. Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior
     David James Pinato, James R. Black, Sebastian Trousil, Roberto E. Dina, Pritesh S. Trivedi, Francesco Angelo Mauri, Rohini Sharma · 2017 · OncoImmunology
130. Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: Role of uric acid accumulation in gemcitabine-induced MICA/B expression
     Xiulong Xu, Geetha Rao, Veronika Groh, Thomas A. Spies, Paolo Gattuso, Howard L. Kaufman, JANET M. D. PLATE, Richard A. Prinz · 2011 · BMC Cancer
131. Hypoxia inducible factor-1 mediates the expression of the immune checkpoint HLA-G in glioma cells through hypoxia response element located in exon 2
     Layale Yaghi, Isabelle Poras, Renata Toscano Simões, Eduardo Antônio Donadi, Jörg Tost, Antoine Daunay, Bibiana Sgorla de Almeida, Edgardo Delfino Carosella, Philippe Moreau · 2016 · Oncotarget
132. Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma
     Abhishek Dinkarnath Garg, Lien Vandenberk, Matthias Van Woensel, Jochen Belmans, Marco B.E. Schaaf, Louis Boon, Steven De Vleeschouwer, Patrizia Agostinis · 2017 · OncoImmunology
133. Targeting CD47 as a cancer therapeutic strategy: the cutaneous T-cell lymphoma experience
     Alecia S. Folkes, Mingye Feng, Jasmine M. Zain, Farah Rukhsana Abdulla, Steven T. Rosen, Christiane Querfeld · 2018 · Current Opinion in Oncology
134. Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo
     De-Kuan Chang, Raymond J. Moniz, Zhongyao Xu, Jiusong Sun, Sabina Signoretti, Quan Karen Zhu, Wayne Anthony Marasco · 2015 · Molecular Cancer
135. Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases
     Debbie M. Ferns, Anne Marijne Heeren, Sanne Samuels, Maaike C.G. Bleeker, Tanja D. de Gruijl, Gemma G. Kenter, Ekaterina S. Jordanova · 2016 · Journal for ImmunoTherapy of Cancer
136. Human leukocyte antigen-G (HLA-G) expression in cervical cancer lesions is associated with disease progression
     Xiang-Juan Li, Xia Zhang, Aifen Lin, Yan-Yun Ruan, Wei‐Hua Yan · 2012 · Human Immunology
137. Checkpoint inhibitors for malignant melanoma: a systematic review and meta-analysis
     Adam Karlsson, Sohag Nafis Saleh · 2017 · Clinical Cosmetic and Investigational Dermatology
138. Fatty Acid Oxidation in Macrophages and T Cells: Time for Reassessment?
     Jan Van den Bossche, Gerritje J. W. van der Windt · 2018 · Cell Metabolism
139. Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma
     Kristian Michael Hargadon · 2017 · Frontiers in Immunology
140. Targeting Resident Memory T Cells for Cancer Immunotherapy
     Charlotte Blanc, Sophie Hans, Thi Tran, Clémence Granier, Antonin Saldmann, Marie Anson, Stéphane Marie. Oudard, Éric Tartour · 2018 · Frontiers in Immunology
141. Group 2 Innate Lymphoid Cells in the Regulation of Immune Responses
     Ben Roediger, Wolfgang Weninger · 2014 · Advances in immunology
142. A functional subset of CD8+ T cells during chronic exhaustion is defined by SIRPα expression
     Myers, Lara M., Tal, Michal Caspi, Torrez Dulgeroff, Laughing Bear, Carmody, Aaron B., Messer, Ronald J., Gulati, Gunsagar, Yiu, Ying Ying, Staron, Matthew M., Angel, Cesar Lopez, Sinha, Rahul et al. · 2019 · Nature Communications
143. Maintenance of CD4 T cell fitness through regulation of Foxo1
     Ryan H. Newton, Sharad Shrestha, Jenna M. Sullivan, Kathleen B. Yates, Ewoud Bernardus Compeer, Noga Ron‐Harel, Bruce R. Blazar, Steven J. Bensinger, W. Nicholas Haining, Michael Loran Dustin et al. · 2018 · Nature Immunology
144. Pluripotent stem cell-derived natural killer cells for cancer therapy
     D. Knorr, D. Kaufman · 2010 · Translational Research: The Journal of Laboratory and Clinical Medicine
145. IRF-5-Mediated Inflammation Limits CD8+ T Cell Expansion by Inducing HIF-1α and Impairing Dendritic Cell Functions during Leishmania Infection
     Akil Hammami, Tania Charpentier, Mélina Smans, Simona Stäger · 2015 · PLoS Pathogens
146. Acidic pH Inhibits Non-MHC-Restricted Killer Cell Functions
     Bianca Fischer, Bernd Müller, Karl-Georg Fischer, Nicole Baur, W. Kreutz · 2000 · Clinical Immunology
147. Hypoxia downregulates the expression of cell surface MICA without increasing soluble MICA in osteosarcoma cells in a HIF-1α-dependent manner
     Naoko Yamada, Koji Yamanegi, Hideki Ohyama, Masaki Hata, Keiji Nakasho, Hiroyuki Futani, Haruki Okamura, Nobuyuki Terada · 2012 · International Journal of Oncology
148. HLA-G Expression in Cancers: Potential Role in Diagnosis, Prognosis and Therapy
     Wei‐Hua Yan · 2011 · Endocrine Metabolic & Immune Disorders - Drug Targets
149. Differential Reliance on Lipid Metabolism as a Salvage Pathway Underlies Functional Differences of T Cell Subsets in Poor Nutrient Environments
     Christopher Ecker, Lili Guo, Stefana Voicu, Luis Gil‐de‐Gómez, Andrew R. Medvec, Luis E. Cortina, Jackie Pajda, Melanie Andolina, Maria Torres-Castillo, Jennifer L. Donato et al. · 2018 · Cell Reports
150. CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival
     Viktor Hendrik Koelzer, Alessandro Lugli, Heather Dawson, Marion Hädrich, Martin D. Berger, Markus Borner, Makhmudbek Mallaev, José A. Galván, Jennifer Amsler, Beat Schnüriger et al. · 2014 · Journal of Translational Medicine
151. Adenosine inhibits activation‐induced T cell expression of CD2 and CD28 co‐stimulatory molecules: Role of interleukin‐2 and cyclic AMP signaling pathways
     Jared J. Butler, Jamie S. Mader, Carrie L. Watson, Hong Zhang, Jonathan Blay, David W. Hoskin · 2003 · Journal of Cellular Biochemistry
152. GITR Agonism Enhances Cellular Metabolism to Support CD8+ T-cell Proliferation and Effector Cytokine Production in a Mouse Tumor Model
     Simran Singh Sabharwal, David Brian Rosen, Jeff Grein, Dana Tedesco, Barbara Joyce-Shaikh, Roanna Ueda, Marie Semana, Michele Bauer, Kathy Bang, Christopher Stevenson et al. · 2018 · Cancer Immunology Research
153. Hypoxic Modulation of HLA-G Expression through the Metabolic Sensor HIF-1 in Human Cancer Cells
     Marica Garziera, Lucia Scarabel, Giuseppe Toffoli · 2017 · Journal of Immunology Research
154. Short‐Term Hypoxia Enhances the Migratory Capability of Dendritic Cell Through HIF‐1α and PI3K/Akt Pathway
     Irene Filippi, Emilia Morena, Carlo Aldinucci, Fabio Carraro, Silvano Sozzani, Antonella Naldini · 2014 · Journal of Cellular Physiology
155. Hypoxia and B cells
     Natalie Burrows, Patrick Henry Maxwell · 2017 · Experimental Cell Research
156. Analysis of Drug Development Paradigms for Immune Checkpoint Inhibitors
     Denis L. Fontes Jardim, Débora De Melo Gagliato, Francis Joseph Giles, Razelle Kurzrock · 2017 · Clinical Cancer Research
157. ATP release and autocrine signaling through P2X4 receptors regulate γδ T cell activation
     Monali Manohar, Mark Hirsh, Yu Chen, Tobias Woehrle, Anjali Anoop Karande, Wolfgang Georg JUNGER · 2012 · Journal of Leukocyte Biology
158. The Ontogeny and Microenvironmental Regulation of Tumor-Associated Macrophages
     Kiavash Movahedi, Jo A. Van Ginderachter · 2016 · Antioxidants and Redox Signaling
159. Loss of Caveolin-1 in Metastasis-Associated Macrophages Drives Lung Metastatic Growth through Increased Angiogenesis
     Ward Celus, Giusy Di Conza, Ana Isabel Oliveira, Manuel Ehling, Bruno Marques Costa, Mathias Wenes, Massimiliano Mazzone · 2017 · Cell Reports
160. HIF-1α hampers dendritic cell function and Th1 generation during chronic visceral leishmaniasis
     Akil Hammami, Belma Melda Abidin, Krista M. Heinonen, Simona Stäger · 2018 · Scientific Reports
161. An acidic microenvironment impairs the generation of non‐major histocompatibility complex‐restricted killer cells
     B. Müller, Beth Fischer, W. Kreutz · 2000 · Immunology
162. Checkpoint immunotherapy in head and neck cancers
     Paul Zolkind, Ravindra Uppaluri · 2017 · Cancer and Metastasis Reviews
163. Deletion of neuropilin 1 from microglia or bone marrow-derived macrophages slows glioma progression
     J. Miyauchi, Michael D. Caponegro, Danling Chen, Matthew Choi, Melvin Li, S. Tsirka · 2017 · Cancer Research
164. pH-Dependent LAK Cell Cytotoxicity
     Thomas M. Severin, Bernd M uuml ller, Guenter Giese, Bianca Uhl, Bernhard Anton Wolf, Sunna Hauschildt, W. Kreutz · 1994 · Tumor Biology
165. Hypoxia inhibits the migratory capacity of human monocyte‐derived dendritic cells
     Xun Qu, Meixiang Yang, Beihua Kong, Lan Qi, Queenie Lai Kwan Lam, Shi Yan, Peng Li, Min Zhang, Liwei Lu · 2005 · Immunology and Cell Biology
166. Selective Growth, In Vitro and In Vivo, of Individual T Cell Clones from Tumor-Infiltrating Lymphocytes Obtained from Patients with Melanoma
     Juhua Zhou, Mark E. Dudley, Steven A. Rosenberg, Paul F. Robbins · 2004 · The Journal of Immunology
167. Nutrient Exploitation within the Tumor–Stroma Metabolic Crosstalk
     Andrea Morandi, Elisa Giannoni, Paola Chiarugi · 2016 · Trends in cancer
168. Hypoxia suppresses the production of matrix metalloproteinases and the migration of humanmonocyte‐derived dendritic cells
     Wenli Zhao, Stephanie Darmanin, Qiang Fu, Jian Chen, Hongyan Cui, Jingxin Wang, Futoshi Okada, Junichi Hamada, Yuu‐ichi Hattori, Takeshi Kondo et al. · 2005 · European Journal of Immunology
169. Targeting VEGF-A in myeloid cells enhances natural killer cell responses to chemotherapy and ameliorates cachexia
     Ralph Klose, Ewelina Krzywińska, Magali Castells, Dagmar Gotthardt, Eva Maria Putz, Chahrazade Kantari‐Mimoun, Naima Chikdene, Anna‐Katharina Meinecke, Katrin Schrödter, Iris Helfrich et al. · 2016 · Nature Communications
170. Safety and clinical activity of adenosine A2a receptor (A2aR) antagonist, CPI-444, in anti-PD1/PDL1 treatment-refractory renal cell (RCC) and non-small cell lung cancer (NSCLC) patients.
     Lawrence H. Fong, Patrick M. Forde, John D. Powderly, Jonathan Wade Goldman, John J. Nemunaitis, Jason J. Luke, Matthew David Hellmann, Shivaani Kummar, Robert Charles Doebele, Daruka Mahadevan et al. · 2017 · Journal of Clinical Oncology
171. PHD2 regulates arteriogenic macrophages through TIE2 signalling
     Alexander Hamm, Lorenzo Veschini, Yukiji Takeda, Sandra Costa, Estelle Delamarre, Mario Leonardo Squadrito, Anne‐Theres Henze, Mathias Wenes, Jens Serneels, Ferdinando Pucci et al. · 2013 · EMBO Molecular Medicine
172. Essential Role of mTORC1 in Self-Renewal of Murine Alveolar Macrophages
     Wenhai Deng, Jialong Yang, Xingguang Lin, Jinwook Shin, Jimin Gao, Xiao‐Ping Zhong · 2016 · The Journal of Immunology
173. An Acidic Microenvironment Inhibits Antitumoral Non–Major Histocompatibility Complex-Restricted Cytotoxicity: Implications for Cancer Immunotherapy
     Bianca Fischer, Bernd Müller, Paul Fisch, W. Kreutz · 2000 · Journal of Immunotherapy
174. Immune checkpoint combinations from mouse to man
     Midan Ai, Michael A. Curran · 2015 · Cancer Immunology Immunotherapy
175. The autophagy sensor ITPR1 protects renal carcinoma cells from NK-mediated killing
     Yosra Messai, Muhammad Zaeem Noman, Bassam Janji, Meriem Hasmim, Bernard J. Escudier, Salem Chouaı̈b · 2015 · Autophagy
176. Dendritic Cells under Hypoxia: How Oxygen Shortage Affects the Linkage between Innate and Adaptive Immunity
     Sandra Winning, Joachim Fandrey · 2016 · Journal of Immunology Research
177. Peripheral Blood Neutrophils as Independent Immunologic Predictor of Response and Long-Term Survival upon Immunotherapy in Metastatic Renal-Cell Carcinoma
     Jens Atzpodien, Martina Reitz · 2008 · Cancer Biotherapy and Radiopharmaceuticals
178. Imaging Cancer Metabolism
     Milica Momcilovic, David B. Shackelford · 2017 · Biomolecules & Therapeutics
179. Low-Dose Cyclophosphamide Synergizes with Dendritic Cell-Based Immunotherapy in Antitumor Activity
     Joris D. Veltman, Margaretha E. H. Lambers, Menno van Nimwegen, Sanne de Jong, Rudi W. Hendriks, Henk C. Hoogsteden, Joachim G.J.V. Aerts, Joost P. Hegmans · 2010 · BioMed Research International
180. The delicate balance of macrophages in colorectal cancer; their role in tumour development and therapeutic potential
     Rens Braster, Marijn Bögels, Robert H.J. Beelen, Marjolein van Egmond · 2015 · Immunobiology
181. Hypoxia enhances indoleamine 2,3-dioxygenase production in dendritic cells
     Xiang Hui Song, Yan Zhang, Li Zhang, Wengang Song, Lixin Shi · 2018 · Oncotarget
182. In vivo tumor cell rejection induced by NK cell inhibitory receptor blockade: Maintained tolerance to normal cells even in the presence of IL‐2
     Gustaf Vahlne, Katja Lindholm, Anders Meier, Stina Linnea Wickström, Tadepally Lakshmikanth, Frank R. Brennan, Michael Wilken, Rikke Nielsen, François Romagné, Nicolai R. Wagtmann et al. · 2009 · European Journal of Immunology
183. Ad.Egr-TNF and Local Ionizing Radiation Suppress Metastases by Interferon-β-Dependent Activation of Antigen-specific CD8+ T Cells
     Yuru Meng, Helena J. Mauceri, Nikolai N. Khodarev, Thomas E. Darga, Sean P. Pitroda, Michael A. Beckett, Donald W. Kufe, Ralph R. Weichselbaum · 2010 · Molecular Therapy
184. Metabolic Regulation of Innate Lymphoid Cell-Mediated Tissue Protection—Linking the Nutritional State to Barrier Immunity
     Christoph Wilhelm, Schekufe Kharabi Masouleh, Alexander Kazakov · 2017 · Frontiers in Immunology
185. HIF-1α is a negative regulator of plasmacytoid DC development in vitro and in vivo
     Andreas Weigert, Benjamin Weichand, Divya Sekar, Weixiao Sha, Christina Hahn, Javier Mora, Stephanie Ley, Silke Essler, Nathalie Dehne, Bernhard Brüne · 2012 · Blood
186. Inclusive estimation of complex antigen presentation functions of monocyte-derived dendritic cells differentiated under normoxia and hypoxia conditions
     Toshitatsu Ogino, Hideya Onishi, Hiroyuki Y. Suzuki, Takashi Morisaki, Masao Tanaka, Mitsuo Katano · 2011 · Cancer Immunology Immunotherapy
187. The Effect of Chemotherapy/Radiotherapy on Cancerous Pattern Recognition by NK Cells
     Benyamin Rosental, Michael Y. Appel, Rami Yossef, Uzi Hadad, Michael Brusilovsky, Angel Porgador · 2012 · Current Medicinal Chemistry
188. miR-210 and hypoxic microvesicles: Two critical components of hypoxia involved in the regulation of killer cells function
     Muhammad Zaeem Noman, Bassam Janji, Guy Berchem, Salem Chouaı̈b · 2015 · Cancer Letters
189. Single dose denileukin diftitox does not enhance vaccine-induced T cell responses or effectively deplete Tregs in advanced melanoma: immune monitoring and clinical results of a randomized phase II trial
     Jason J. Luke, Yuanyuan Zha, Karen Matijevich, Thomas F. Gajewski · 2016 · Journal for ImmunoTherapy of Cancer
190. Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth
     Jae-Hwan Lee, Y. Shin, Kyoungmin Lee, H. Cho, J. Sa, Sang‐Yun Lee, Seok-Hyung Kim, Jeongwu Lee, Yeup Yoon, D. Nam · 2017 · Cancer research and treatment : official journal of Korean Cancer Association
191. PHD2 Targeting Overcomes Breast Cancer Cell Death upon Glucose Starvation in a PP2A/B55α-Mediated Manner
     Giusy Di Conza, Sarah Trusso Cafarello, Xingnan Zheng, Qing Hua Zhang, Massimiliano Mazzone · 2017 · Cell Reports
192. AntiCD3Fv fused to human interleukin-3 deletion variant redirected T cells against human acute myeloid leukemic stem cells
     Dongmei Fan, Zhenzhen Li, Xiaolong Zhang, Yuqi Yang, Xiangfei Yuan, Xiuli Zhang, Ming Yang, Yizhi Zhang, Dongsheng Xiong · 2015 · Journal of Hematology & Oncology
193. Gemcitabine inhibits immune escape of pancreatic cancer by down regulating the soluble ULBP2 protein
     Xiansheng Lin, Mei Huang, Fang Xie, Hangcheng Zhou, Ji Hyun Yang, Qiang Huang · 2016 · Oncotarget
194. Targeting NKG2D and NKp30 Ligands Shedding to Improve NK Cell-Based Immunotherapy
     Alessandra Zingoni, Elisabetta Vulpis, Ilaria Nardone, Alessandra Soriani, Cinzia Fionda, Marco Cippitelli, Angela Santoni · 2016 · Critical Reviews in Immunology
195. HLA-G in Melanoma: A New Strategy to Escape from Immunosurveillance?
     Selma Ugurel, Uwe Reinhold, Wolfgang Tilgen · 2002 · Oncology Research and Treatment
196. Translating In Vitro T Cell Metabolic Findings to In Vivo Tumor Models of Nutrient Competition
     Christopher Ecker, James L. Riley · 2018 · Cell Metabolism
197. A New Perspective on the Heterogeneity of Cancer Glycolysis
     Michael L. Neugent, Justin Goodwin, Ishwarya Sankaranarayanan, Emre C. Yetkin, Meng-Hsiung Hsieh, Jung‐whan Kim · 2017 · Biomolecules & Therapeutics
198. Irradiation-Induced Up-Regulation of HLA-E on Macrovascular Endothelial Cells Confers Protection against Killing by Activated Natural Killer Cells
     Isabelle Riederer, Wolfgang Sievert, Günther Eißner, M. Molls, Gabriele Multhoff · 2010 · PLoS ONE
199. Microenvironmental stresses induce HLA‐E/Qa‐1 surface expression and thereby reduce CD8+ T‐cell recognition of stressed cells
     Takanori Sasaki, Takayuki Kanaseki, Yosuke Shionoya, Serina Tokita, Sho Miyamoto, Eri Saka, Vitaly Kochin, Akira Takasawa, Yoshihiko Hirohashi, Yasuaki Tamura et al. · 2015 · European Journal of Immunology
200. N-linked carbohydrates in tyrosinase are required for its recognition by human MHC class II-restricted CD4+ T cells
     Franck Housseau, Anitha Moorthy, Daniël Langer, Paul F. Robbins, Monica I. Gonzales, Suzanne Louise Topalian · 2001 · European Journal of Immunology